ERBB2 and breast carcinoma: In this context, we have selected the mouse DD-Her2/neu breast cancer model to evaluate the efficacy of the PTT-FlaB-Vax combination in inducing locoregional and systemic/abscopal immune responses that suppress recurrence and metastasis.